Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $32.7500 (1.52%) ($31.8540 - $32.8400) on Fri. Oct. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.28% (three month average) | RSI | 65 | Latest Price | $32.7500(1.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(57%) ARKG(55%) IWC(54%) IBUY(53%) | Factors Impacting EDIT price | EDIT will decline at least -2.14% in a week (0% probabilities). VIXM(-28%) UUP(-14%) VXX(-12%) EDOC(-8%) TBT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.14% (StdDev 4.28%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $32.38(1.14%) | 10 Day Moving Average | $32.48(0.83%) | 20 Day Moving Average | $31.05(5.48%) | To recent high | -11.8% | To recent low | 20.9% | Market Cap | $2.034b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |